Global Scales for Cognitive Screening in Parkinson's Disease:
Critique and Recommendations

J 2018

Global Scales for Cognitive Screening in Parkinson's Disease: Critique and Recommendations

SKORVANEK, M., J.G. GOLDMAN, M. JAHANSHAHI, C. MARRAS, Irena REKTOROVÁ et. al.

Basic information

Original name

Global Scales for Cognitive Screening in Parkinson's Disease: Critique and Recommendations

Authors

SKORVANEK, M. (703 Slovakia), J.G. GOLDMAN (276 Germany), M. JAHANSHAHI (826 United Kingdom of Great Britain and Northern Ireland), C. MARRAS (124 Canada), Irena REKTOROVÁ (203 Czech Republic, guarantor, belonging to the institution), B. SCHMAND (528 Netherlands), E. VAN DUIJN (528 Netherlands), C.G. GOETZ (840 United States of America), D. WEINTRAUB (840 United States of America), G.T. STEBBINS (840 United States of America) and P. MARTINEZ-MARTIN (724 Spain)

Edition

Movement Disorders, Hoboken, Wiley-Blackwell, 2018, 0885-3185

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30103 Neurosciences

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 8.222

RIV identification code

RIV/00216224:14740/18:00106658

Organization unit

Central European Institute of Technology

DOI

http://dx.doi.org/10.1002/mds.27233

UT WoS

000424815100005

Keywords in English

Parkinson's disease; cognitive; dementia; rating scales; clinimetric

Abstract

V originále

Background: Cognitive impairment is a common nonmotor manifestation of Parkinson's disease, with deficits ranging from mild cognitive difficulties in 1 or more of the cognitive domains to severe dementia. The International Parkinson and Movement Disorder Society commissioned the assessment of the clinimetric properties of cognitive rating scales measuring global cognitive performance in PD to make recommendations regarding their use. Methods: A systematic literature search was conducted to identify the scales used to assess global cognitive performance in PD, and the identified scales were reviewed and rated as "recommended," "recommended with caveats," "suggested," or "listed" by the panel using previously established criteria. Results: A total of 12 cognitive scales were included in this review. Three scales, the Montreal Cognitive Assessment, the Mattis Dementia Rating Scale Second Edition, and the Parkinson's Disease-Cognitive Rating Scale, were classified as "recommended." Two scales were classified as "recommended with caveats": the Mini-Mental Parkinson, because of limited coverage of executive abilities, and the Scales for Outcomes in Parkinson's Disease-Cognition, which has limited data on sensitivity to change. Six other scales were classified as "suggested" and 1 scale as "listed." Conclusions: Because of the existence of "recommended" scales for assessment of global cognitive performance in PD, this task force suggests that the development of a new scale for this purpose is not needed at this time. However, global cognitive scales are not a substitute for comprehensive neuropsychological testing. (C) 2017 International Parkinson and Movement Disorder Society

Citovat

SKORVANEK, M., J.G. GOLDMAN, M. JAHANSHAHI, C. MARRAS, Irena REKTOROVÁ, B. SCHMAND, E. VAN DUIJN, C.G. GOETZ, D. WEINTRAUB, G.T. STEBBINS and P. MARTINEZ-MARTIN. Global Scales for Cognitive Screening in Parkinson's Disease: Critique and Recommendations. Movement Disorders. Hoboken: Wiley-Blackwell, 2018, vol. 33, No 2, p. 208-218. ISSN 0885-3185. Available from: https://dx.doi.org/10.1002/mds.27233.

@article{1507698,
   author = {Skorvanek, M. and Goldman, J.G. and Jahanshahi, M. and Marras, C. and Rektorová, Irena and Schmand, B. and van Duijn, E. and Goetz, C.G. and Weintraub, D. and Stebbins, G.T. and MartinezandMartin, P.},
   article_location = {Hoboken},
   article_number = {2},
   doi = {http://dx.doi.org/10.1002/mds.27233},
   keywords = {Parkinson's disease; cognitive; dementia; rating scales; clinimetric},
   language = {eng},
   issn = {0885-3185},
   journal = {Movement Disorders},
   title = {Global Scales for Cognitive Screening in Parkinson's Disease: Critique and Recommendations},
   volume = {33},
   year = {2018}
}

TY  - JOUR
ID  - 1507698
AU  - Skorvanek, M. - Goldman, J.G. - Jahanshahi, M. - Marras, C. - Rektorová, Irena - Schmand, B. - van Duijn, E. - Goetz, C.G. - Weintraub, D. - Stebbins, G.T. - Martinez-Martin, P.
PY  - 2018
TI  - Global Scales for Cognitive Screening in Parkinson's Disease: Critique and Recommendations
JF  - Movement Disorders
VL  - 33
IS  - 2
SP  - 208-218
EP  - 208-218
PB  - Wiley-Blackwell
SN  - 08853185
KW  - Parkinson's disease
KW  - cognitive
KW  - dementia
KW  - rating scales
KW  - clinimetric
N2  - Background: Cognitive impairment is a common nonmotor manifestation of Parkinson's disease, with deficits ranging from mild cognitive difficulties in 1 or more of the cognitive domains to severe dementia. The International Parkinson and Movement Disorder Society commissioned the assessment of the clinimetric properties of cognitive rating scales measuring global cognitive performance in PD to make recommendations regarding their use. Methods: A systematic literature search was conducted to identify the scales used to assess global cognitive performance in PD, and the identified scales were reviewed and rated as "recommended," "recommended with caveats," "suggested," or "listed" by the panel using previously established criteria. Results: A total of 12 cognitive scales were included in this review. Three scales, the Montreal Cognitive Assessment, the Mattis Dementia Rating Scale Second Edition, and the Parkinson's Disease-Cognitive Rating Scale, were classified as "recommended." Two scales were classified as "recommended with caveats": the Mini-Mental Parkinson, because of limited coverage of executive abilities, and the Scales for Outcomes in Parkinson's Disease-Cognition, which has limited data on sensitivity to change. Six other scales were classified as "suggested" and 1 scale as "listed." Conclusions: Because of the existence of "recommended" scales for assessment of global cognitive performance in PD, this task force suggests that the development of a new scale for this purpose is not needed at this time. However, global cognitive scales are not a substitute for comprehensive neuropsychological testing. (C) 2017 International Parkinson and Movement Disorder Society
ER  -

SKORVANEK, M., J.G. GOLDMAN, M. JAHANSHAHI, C. MARRAS, Irena REKTOROVÁ, B. SCHMAND, E. VAN DUIJN, C.G. GOETZ, D. WEINTRAUB, G.T. STEBBINS and P. MARTINEZ-MARTIN. Global Scales for Cognitive Screening in Parkinson's Disease: Critique and Recommendations. \textit{Movement Disorders}. Hoboken: Wiley-Blackwell, 2018, vol.~33, No~2, p.~208-218. ISSN~0885-3185. Available from: https://dx.doi.org/10.1002/mds.27233.

Detailed Information on Publication Record